Top Markets
#1 PulseChain PulseChain +45.01%
#2 Not in Employment, Education, or Training Not in Employment, Education, or Training +17.88%
#3 MarsCoin MarsCoin +17.39%
#4 RedStone RedStone +15.77%
#5 Bitway Bitway +11.33%
#6 SkyAI SkyAI +10.21%
#7 Meteora Meteora +9.28%
#8 Lorenzo Wrapped Bitcoin Lorenzo Wrapped Bitcoin +8.13%
#9 Lighter Lighter +8.05%
#10 Monad Monad +7.59%
Coin of the day
PulseChain PulseChain
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
GeneReach Biotechnology Corp. GeneReach Biotechnology Corp.

GeneReach Biotechnology Corp.

4171
Kedudukan dalam Saham #27717
GeneReach Biotechnology Corp., a company based in Taichung, Taiwan, specializes... GeneReach Biotechnology Corp., a company based in Taichung, Taiwan, specializes in the development, production, and commercialization of advanced nucleic acid detection technologies. The company's extensive product line features essential laboratory instrumentation, including automated nucleic acid extraction systems, prep homogenization systems, and mini centrifuges. GeneReach also provides a wide range of reagents and consumables, such as human In Vitro Diagnostic (IVD) assays, specific iiPCR reagents, taco nucleic acid extraction reagents, IQ real quantitative systems, IQ2000 detection and prevention systems, and various research-grade reagents and supplies. Beyond its product offerings, GeneReach delivers comprehensive services. These encompass polymerase chain reaction (PCR) training programs, expert molecular diagnostic technical solutions, laboratory installation assistance, OEM/ODM contract manufacturing capabilities, and collaborative research services. Its innovative solutions cater to a diverse clientele, with applications spanning aquaculture, agriculture, food safety, human health, and the welfare of companion animals and livestock. GeneReach Biotechnology Corp. was established in 2004.
Harga Saham
$0.54853323
Modal Pasaran
$31.43M
Perubahan (1 hari)
0.58%
Perubahan (1 tahun)
-18.14%
Negara
TW
Perdagangan GeneReach Biotechnology Corp. (4171)

Kategori

Healthcare
Hasil untuk GeneReach Biotechnology Corp. (4171)
Hasil pada Aug 2026 TTM: 0
Menurut laporan kewangan terkini daripada GeneReach Biotechnology Corp., hasil semasa syarikat (TTM) ialah 0. Pada tahun 2026, syarikat memperoleh hasil sebanyak 0 sama dengan hasil pada tahun 2026 iaitu 0. Hasil ialah jumlah pendapatan keseluruhan yang dijana oleh syarikat daripada jualan barangan atau perkhidmatan. Tidak seperti keuntungan, tiada perbelanjaan ditolak.
Sejarah hasil bagi GeneReach Biotechnology Corp. dari 2026 hingga 2026
Hasil pada akhir setiap tahun
Tahun Hasil Ubah
Tidak cukup data untuk tarikh yang disediakan.
Hasil untuk syarikat atau pesaing serupa
Syarikat Hasil Perbezaan Hasil Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.70B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH